NeuroStar TMS Therapy® Provider | (559) 493-5544 | 1312 W. Herndon Ave. Suite 102 Fresno, CA 93711

NeuroStar TMS Therapy

NeuroStar TMS Therapy is the first and only non-systemic and non-invasive outpatient depression treatment cleared by the US Food and Drug Administration (FDA) for patients who have not benefited from prior antidepressant treatment. NeuroStar TMS Therapy uses highly focused, pulsed magnetic fields to stimulate function in targeted brain regions.

NeuroStar TMS Therapy is:

  • Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment.
  • Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.

NeuroStar Effectivness

Clinical trials have demonstrated the effectiveness of NeuroStar® TMS Therapy in treating patients who have not benefited from prior antidepressant medication. NeuroStar TMS Therapy was studied in adult patients suffering from Major Depressive Disorder, all of whom had not received satisfactory improvement with previous treatments.

An Effective Option for Treating Major Depressive Disorder

In a study where 307 patients received active treatment (similar to a real clinical context), as well as a 12 month follow up, over half of the patients treated with NeuroStar TMS Therapy experienced significant improvement in their depression symptoms. About a third of the patients treated with NeuroStar TMS Therapy experienced complete symptom relief at the end of six weeks. The study consisted of 307 available unipolar, non-psychotic MDD patients in acute phase.

Patients treated with NeuroStar® also experienced significant improvement in anxiety and physical symptoms (such as appetite changes, aches and pains, and lack of energy) associated with depression.

Additionally, Neuronetics has developed a new tool to use in educating patients on the best practices of treating depression. The Best Practices Treatment Guideline for Depression has been developed to help patients understand TMS Therapy as an option if their first line antidepressant medications stop working. This guideline is based on the 2010 American Psychiatric Association's practice guidelines and NeuroStar TMS Therapy indication for use, which says:

  • NeuroStar TMS Therapy is indicated for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication at or above the minimal effective dose and duration in the current episode.

NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment. Its effectiveness has also not been established in patients that have failed to receive benefit from two or more prior antidepressant medications at minimal effective dose and duration in the current episode.

NeuroStar Safety

Clinical trials have demonstrated the safety of NeuroStar TMS Therapy® in treating patients who have had an inadequate response to prior antidepressant medications.

Treatment with NeuroStar TMS Therapy caused very few side effects and was generally well tolerated by patients. The most common side effect reported during clinical trials was scalp discomfort—generally mild to moderate and occurring less frequently after the first week of treatment.

Over 10,000 active treatments were performed across all NeuroStar® clinical trials demonstrating its safety

  • No systemic side effects
  • No adverse effects on concentration or memory
  • No drug interactions
  • NeuroStar TMS Therapy should not be used in patients with implanted metallic devices or non-removable metallic objects in or around the head. This does not include metallic fillings in teeth.
  • NeuroStar TMS Therapy should not be used in patients with implants controlled by physiological signals. This includes pacemakers, implantable cardioverter defibrillators (ICDs), and vagus nerve stimulators (VNS).
Dr. Oz Video on TMS
Call Now Image
Fresno TMS Videos Image TMS FAQS Image Fresno TMS Therapy EMAIL Image
| PRIVACY / DISCLAIMER | SITEMAP | CONTACT US |

Copyright © 2019 Esano Corporation All Rights Reserved. | NeuroStar TMS Therapy® Provider Fresno, CA | (559) 493-5544

Printed from www.fresnotmstherapy.com/neurostar-tms-therapy

Bradley T. Wajda, D.O. PC
1312 W Herndon Ave, Suite 102
Fresno, CA 93711
Phone: (559) 493-5544
Fax: (559) 493-5166

SEObuilt Find us on FacebookFind us on YouTubeFind us on EsanoHealth.comFind us on RadioPsyched.com